NCT00582569View on ClinicalTrials.gov

Breast MRI Spectroscopy, Department of Defense (DOD)

CompletedOBSERVATIONAL
Enrollment

146

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Breast Lesion
Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00582569 - Breast MRI Spectroscopy, Department of Defense (DOD) | Biotech Hunter | Biotech Hunter